Recognition of pathogen-associated molecules in microbes by TLRs leads to activation of transcription factors such as NF-κB that promote increased transcription of proinflammatory cytokines and interferons 1 . All mammalian TLRs, with the exception of TLR3, use the adaptor MyD88 as the receptor-proximal signaling molecule to trigger downstream activation of NF-κB 2 . The association of MyD88 with TLRs facilitates recruitment of members of the IRAK family of kinases that in turn activate the E3 ubiquitin ligase TRAF6 (refs. 3-5). The formation of polyubiquitin chains by TRAF6 serves to bring TAK1 into close proximity with its substrates, including IκB kinases (IKKs). The TAK1-induced phosphorylation and activation of IKKα and IKKβ promotes IKK-induced phosphorylation of IκB proteins 6 that normally sequester NF-κB in an inactive form in the cytoplasm. Phosphorylated forms of IκB are subject to polyubiquitination and subsequently proteasome-dependent degradation, thus liberating NF-κB to translocate to the nucleus and transcriptionally upregulate the expression of a plethora of genes 7 . Most TLRs use this MyD88-dependent pathway to activate NF-κB, but TLR4 can additionally deploy another adaptor protein, TRIF, to trigger a MyD88-independent pathway that also activates NF-κB 8 . Among TLRs, TLR3 uses TRIF as its exclusive receptor-proximal adaptor protein. TRIF interacts with RIP1 kinase to trigger downstream IKK-mediated activation of NF-κB 9,10 . TRAF6 has been reported to associate with TRIF and mediate activation of NF-κB 11-13 , but other studies had concluded that TRAF6 is dispensable for TLR3 signaling 14, 15 . Such discrepancies in relation to the role of TRAF6 in TRIF signaling may be due to cell-specific roles for TRAF6 and/or functional redundancy of TRAF6 with other members of the TRAF family 11 . In addition to activation of NF-κB, TRIF can also trigger activation of interferon-regulatory factor (IRF) transcription factors. Thus, TRIF forms a complex with the kinases TBK1 and IKKi (also known as IKKε) and both kinases can catalyze phosphorylation and activation of IRF3 and IRF7, leading to their nuclear translocation and induction of type I interferons 1, 16 . The latter are key antiviral molecules that block viral replication 17, 18 .
Recognition of pathogen-associated molecules in microbes by TLRs leads to activation of transcription factors such as NF-κB that promote increased transcription of proinflammatory cytokines and interferons 1 . All mammalian TLRs, with the exception of TLR3, use the adaptor MyD88 as the receptor-proximal signaling molecule to trigger downstream activation of NF-κB 2 . The association of MyD88 with TLRs facilitates recruitment of members of the IRAK family of kinases that in turn activate the E3 ubiquitin ligase TRAF6 (refs. 3-5) . The formation of polyubiquitin chains by TRAF6 serves to bring TAK1 into close proximity with its substrates, including IκB kinases (IKKs). The TAK1-induced phosphorylation and activation of IKKα and IKKβ promotes IKK-induced phosphorylation of IκB proteins 6 that normally sequester NF-κB in an inactive form in the cytoplasm. Phosphorylated forms of IκB are subject to polyubiquitination and subsequently proteasome-dependent degradation, thus liberating NF-κB to translocate to the nucleus and transcriptionally upregulate the expression of a plethora of genes 7 . Most TLRs use this MyD88-dependent pathway to activate NF-κB, but TLR4 can additionally deploy another adaptor protein, TRIF, to trigger a MyD88-independent pathway that also activates NF-κB 8 . Among TLRs, TLR3 uses TRIF as its exclusive receptor-proximal adaptor protein. TRIF interacts with RIP1 kinase to trigger downstream IKK-mediated activation of NF-κB 9, 10 . TRAF6 has been reported to associate with TRIF and mediate activation of NF-κB [11] [12] [13] , but other studies had concluded that TRAF6 is dispensable for TLR3 signaling 14, 15 . Such discrepancies in relation to the role of TRAF6 in TRIF signaling may be due to cell-specific roles for TRAF6 and/or functional redundancy of TRAF6 with other members of the TRAF family 11 . In addition to activation of NF-κB, TRIF can also trigger activation of interferon-regulatory factor (IRF) transcription factors. Thus, TRIF forms a complex with the kinases TBK1 and IKKi (also known as IKKε) and both kinases can catalyze phosphorylation and activation of IRF3 and IRF7, leading to their nuclear translocation and induction of type I interferons 1, 16 . The latter are key antiviral molecules that block viral replication 17, 18 .
It is clear from the above that ubiquitination is important in TLR signal transduction. Additionally, there is an emerging appreciation of the roles of the E3 ubiquitin ligase family of Pellino proteins in TLR signaling. The mammalian Pellino family consists of four members: Pellino1, Pellino2 and splice variants of Pellino3 termed Pellino3 long (Pellino3L; also known as Pellino3a) and Pellino3 short (Pellino3S; also known as Pellino3b) 19, 20 . Each Pellino family member contains an N-terminal forkhead-associated (FHA) domain that recognizes phosphothreonine residues and mediates association with IRAKs 21 , and a C-terminal RING-like domain that confers E3 ubiquitin ligase activity and an ability to catalyze lysine 63 (Lys63)-linked polyubiquitination of IRAKs [22] [23] [24] . Pellino proteins are subject to various forms of post-translational modification, including phosphorylation [24] [25] [26] [27] [28] , ubiquitination [23] [24] [25] and sumoylation 29 with phosphorylation being especially important for enhancing the E3 ligase activity. Pellino1 is regulated at the transcriptional level by TRIF signaling, which induces Pellino1 expression in an IRF3-dependent manner 26 . Although each of the Pellino proteins has most of the above features, there are unique functional differences. Pellino1 has been shown to act as a mediator in the NF-κB pathway 30 , whereas Pellino2 and Pellino3 have been associated with activation of MAPK pathways 28, [31] [32] [33] [34] . The generation of Pellino1-deficient mice had revealed a role for Pellino1 as the E3 1 0 5 6 VOLUME 13 NUMBER 11 NOVEMBER 2012 nature immunology A r t i c l e s ubiquitin ligase for RIP1 and a critical mediator of TRIF-dependent activation of NF-κB in TLR3 and TLR4 pathways 35 . Pellino1 has been shown to negatively regulate T cell activation and suppress autoimmunity by promoting ubiquitination and proteolysis of the NF-κB subunit c-Rel in activated T cells 36, 37 . To date the physiological roles of Pellino2 and Pellino3 remain to be defined.
We report the generation of Pellino3-deficient mice and describe a new physiological role for Pellino3 in TLR signaling. We show that Pellino3 is dispensable for TLR-induced expression of proinflammatory cytokines but has a negative regulatory role in TLR3-and viral-induced expression of type I interferon and related genes. Mechanistically, we show that TRIF signaling induces Pellino3 expression, which in turn inhibits the ability of TRAF6 to activate IRF7. These findings reveal Pellino3 as an important player in a new autoregulatory system for controlling type I interferon expression.
RESULTS

Pellino3 regulates TLR3 induction of type I interferon
We generated Pellino3-deficient mice with a floxed Peli3 allele (Supplementary Fig. 1a) . We detected wild-type and recombined alleles by PCR analysis (Supplementary Fig. 1b) . Semi-quantitative and real-time RT-PCR analysis of mRNA isolated from mouse embryonic fibroblasts (MEFs) demonstrated absence of Pellino3 mRNA expression in cells from Peli3 −/− mice ( Supplementary Fig. 1c,d ).
Initially we used bone marrow-derived macrophages (BMDMs) from wild-type and Peli3 −/− mice to assess the effects of Pellino3 deficiency on TLR signaling. The ability of various TLR ligands to induce proinflammatory cytokines, such as TNF and IL-6, was comparable in BMDMs from wild-type and Pellino3-deficient mice as determined by enzyme-linked immunosorbent assay (ELISA; Fig. 1a) , indicating a nonessential role for Pellino3 in mediating TLR-induced expression of proinflammatory cytokines. Various TLR ligands were similarly effective in inducing TNF in MEFs isolated from wildtype and Peli3 −/− mice (Supplementary Fig. 2a ). Given that TLRs are highly expressed in various dendritic cell (DC) populations, we characterized the effects of Pellino3 deficiency on IL-6 expression in response to TLR3, TLR4 and TLR9 signaling in myeloid DCs (mDCs) and plasmacytoid DCs (pDCs; Supplementary Fig. 2b,c) . Absence of Pellino3 had no effect on the TLR-mediated induction of IL-6 in these DC populations.
We next examined a potential role of Pellino3 in regulating the expression of type I interferons and interferon-stimulated genes, such as the chemokine CXCL10. We stimulated BMDMs with ligands for TLR3, TLR4, TLR7 and TLR9 because these are the predominant TLR family members that induce type I interferons, and measured the induction of interferon beta (IFN-β). Each of the ligands induced IFN-β in wild-type BMDMs, but the TLR3 agonist polyriboinosinic: polyribocytidylic acid (poly(I:C)) was unique in that its efficacy in inducing IFN-β was augmented in Pellino3-deficient BMDMs compared with wild-type BMDMs (Fig. 1b) . Peli3 −/− cells also exhibited selective enhancement of poly(I:C)-induced expression of CXCL10 (Fig. 1c) . Poly(I:C) similarly induced higher IFN-α expression in Peli3 −/− BMDMs relative to their wild-type counterparts (Fig. 1d) . The type I interferon produced in these cells was bioactive, as shown in a type I interferon reporter cell line (Fig. 1e) . We also measured type I interferon and CXCL10 induction in MEFs, mDCs and pDCs stimulated with various TLR ligands (Supplementary Fig. 2 ). We observed enhanced induction of type I interferon and CXCL10 by poly(I:C) in Pellino3-deficient MEFs and mDCs. This effect was mediated by increased gene transcription because poly(I:C) induced greater amounts of Ifnb1 mRNA in Pellino3-deficient BMDMs relative to wild-type cells, whereas poly(I:C)-mediated induction of Tnf mRNA was independent of Pellino3 deficiency (Fig. 1f) . The regulatory effects of Pellino3 on type I interferon expression seemed to be restricted to TLR3 because Pellino3 deficiency did not affect LPSmediated induction of Ifnb1 or Tnf mRNA in BMDMs (Fig. 1g) . 
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To confirm the regulatory effects of Pellino3 in poly(I:C) signaling in vivo, we injected wild-type and Pellino3-deficient mice intraperitoneally with poly(I:C), isolated peritoneal exudate cells (PECs) and assayed them for expression of genes encoding IFN-β, RANTES and TNF (Ifnb1, Ccl5 and Tnf, respectively). The chemokine RANTES was included in this analysis because, similar to type I interferon, its expression is regulated by IRFs. In vivo administration of poly(I:C) induced expression of Ifnb1 and Ccl5 in wild-type mice, and this was enhanced in Pellino3-deficient mice (Fig. 1h) . In contrast, poly(I:C)-mediated induction of Tnf was similar in wild-type and Peli3 −/− mice, indicating that Pellino3 selectively regulates expression of type I interferons and related genes without affecting expression of proinflammatory genes.
Given that poly(I:C) can stimulate both TLR3 and the cytosolic receptor MDA-5 (ref. 38) , we investigated which of the two pathways is potentially modulated by Pellino3 in this experimental system. We observed loss of induction of Ifnb1, Ccl5 and Tnf mRNAs, which encode IFN-β, RANTES and TNF, respectively, in response to poly (I:C) in TRIF-deficient BMDMs but not in BMDMs deficient in the signaling adaptor MAVS (Supplementary Fig. 3a) . Given the role of TRIF in TLR3 signaling and MAVS in MDA-5 signaling, these results provide evidence that TLR3 is the primary sensing receptor for poly(I:C) in BMDMs. In addition, we applied poly(I:C) to cells directly, which favors stimulation of TLR3, whereas MDA-5-mediated responses to poly(I:C) require transfection of cells for delivery of the synthetic dsRNA to the cytosol. To confirm that Pellino3 targets TLR3 in our model, we tested the effect of direct application or liposome-mediated delivery of poly(I:C) to wild-type and Pellino3-deficient BMDMs on IFN-β expression. Both delivery methods induced IFN-β in wild-type BMDMs. IFN-β induction was enhanced in Pellino3-deficient cells in response to direct application of poly(I:C) but not in response to transfection-mediated delivery (Supplementary Fig. 3b ). These findings suggest that Pellino3 selectively targets the TLR3 pathway.
We next addressed the regulatory effects of Pellino3 on TLR3-induced expression of type I interferon and related genes in human cells. We established U373 cell lines transduced with lentivirus to stably express PELI3-specific short hairpin RNA (shRNA) or a control shRNA. We confirmed knockdown of Pellino3 expression by RT-PCR (Supplementary Fig. 4a ). Expression of IFNB1, IFNA1, CCL5 and CXCL10 mRNA, in response to poly(I:C) stimulation for various times, was greatly enhanced under conditions of Pellino3 knockdown ( Supplementary Fig. 4b-e) . We also observed enhanced expression at the protein level ( Supplementary Fig. 4f,g ). Poly(I:C)-induced expression of IL6 mRNA or protein were not affected in Pellino3 knockdown U373 cells (Supplementary Fig. 4h,i) . Together, these results indicate a selective role for Pellino3 as a negative regulator of TLR3-induced expression of type I interferon but not of proinflammatory genes.
Enhanced protection from EMCV infection in Peli3 −/− mice Given that poly(I:C) is a synthetic analog of viral dsRNA, we investigated the role of Pellino3 in regulating the host response to EMCV, which generates dsRNA as part of its life cycle and for which TLR3 signaling has been shown to be important for a protective response 39 . EMCV induced IFN-β, IFN-α, CXCL10 and TNF in wild-type BMDMs. Whereas expression of type I interferon and CXCL10 was additionally enhanced in Peli3 −/− cells, EMCV-induced TNF was not affected by Pellino3 deficiency (Fig. 2a) . We obtained similar results in Pellino3-deficient MEFs (Fig. 2b) . The enhanced production of type I interferons was bioactive (Fig. 2c) . Pellino3-deficient MEFs showed enhanced induction of the mRNAs encoding IFN-β, IFN-α and CXCL10 in response to EMCV challenge relative to wildtype cells (Fig. 2d) . Loss of Pellino3 had no effect on the Tnf mRNA induced by EMCV, suggesting Pellino3 specifically regulates type I interferon gene expression in response to EMCV.
We next investigated the physiological and pathological relevance of these regulatory effects of Pellino3 in the context of EMCV infection with two lethal viral doses in wild-type and Peli3 −/− mice. The higher infection dose of 250 plaque-forming units (PFU) per mouse had a lethal effect in all wild-type mice 7 d after infection (Fig. 3a) , whereas 60% of Pellino3-deficient mice survived and remained healthy for the duration of the infection study. A lower dose of EMCV (50 PFU per mouse) caused 50% lethality in wildtype mice 10 d after infection, whereas all Pellino3-deficient mice survived (Fig. 3a) . An increased heart/body weight ratio, characteristic of EMCV infections, was clearly evident in wild-type mice but not in Pellino3-deficient mice at low doses of infection (Fig. 3b) . Examination of heart tissue from EMCV-infected wild-type mice by microscopy revealed histopathological changes with random multifocal mononuclear interstitial infiltrates as well as myofiber nuclear karyolysis and myofiber cell loss accompanied by mild edema (Fig. 3c) . We did not observe these changes in the heart tissue from EMCV-infected Peli3 −/− mice. Enhanced protection from the pathological and lethal effects of EMCV infection in Pellino3-deficient mice was associated with a lower viral load in the hearts, as measured by expression of the replicase gene from EMCV (Fig. 3d) . . NS, not significant,*P < 0.05, **P < 0.01 and ***P < 0.001 (paired Student's t-test).
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This was consistent with enhanced IFN-β expression in the hearts from EMCV-infected Peli3 −/− mice (Fig. 3e) , which presumably facilitated more efficient clearance of the virus. Expression of TNF in the heart of EMCV-infected Peli3 −/− mice was lower than that in infected wild-type mice (Fig. 3f) , correlating with the lower grade of inflammation suggested by the histochemical analysis (Fig. 3c) . Thus, Pellino3 has an important regulatory function in controlling type I interferon expression in response to viral challenge.
Pellino3 selectively regulates activation of IRF7
Because the type I interferon and related genes that are inhibited by Pellino3 are strongly regulated by NF-κB and IRFs, we compared these pathways in response to poly(I:C) in wild-type and Pellino3-deficient cells. The absence of Pellino3 did not affect the capacity of poly(I:C) to induce phosphorylation of IKKs or of their substrate IκBα, both of which are activation indices of the canonical NF-κB pathway (Fig. 4a) . To investigate the activation of IRFs, we assessed the binding of nuclear extracts to an oligonucleotide containing the IRF recognition motif from the positive regulatory domains I/III (PRD I/III) of the enhancer region of the Ifnb1 gene. Poly(I:C) induced a modest and time-dependent increase in the binding of nuclear extract proteins from wild-type cells to the PRD I/III motif, whereas binding was enhanced in extracts from Pellino3-deficient cells (Fig. 4b) , suggestive of a role for Pellino3 in targeting the IRF arm of the TLR3 pathway. However, loss of Pellino3 did not affect the ability of poly(I:C) to promote phosphorylation of IRF3 or its upstream kinase TBK1 (Fig. 4c) . Given that IRF7 can also bind to the PRD I/III domain, we probed the regulatory effect of Pellino3 on the phosphorylation of IRF7, which is required for its activation. Because commercially available phosphospecific IRF7 antibodies are only sufficiently sensitive to detect overexpressed IRF7, we characterized the poly(I:C)-induced phosphorylation of IRF7 expressed in HEK293 cells, stably expressing TLR3 and transfected with shRNA targeting PELI3. In this system, poly(I:C) promoted time-dependent phosphorylation of IRF7 in cells transfected with a control shRNA, and this was enhanced in Pellino3-knockdown cells (Fig. 4d) . We next probed the regulatory effect of Pellino3 on the phosphorylation of endogenous IRF7. Given the lack of sensitivity of the phospho-IRF7 antibody, we immunoblotted for serine phosphorylation of IRF7 immunoprecipitated from mDCs that had been stimulated with poly(I:C). The amount of serine-phosphorylated IRF7 was higher in Pellino3-deficient mDCs relative to that in wild-type mDCs (Fig. 4e) .
Because phosphorylation of IRF7 is a prerequisite for its nuclear translocation, we next assessed the effects of Pellino3 deficiency on the nuclear localization of IRF7. We isolated nuclear fractions from wild-type and Pellino3-deficient BMDMs that had been stimulated with poly(I:C) for various durations. Time-dependent poly(I:C)-induced nuclear localization of IRF7 was stronger in Peli3 −/− than in wild-type BMDMs (Fig. 4f) . Whereas poly(I:C) also caused increased nuclear localization of IRF3, this was not affected by the absence of Pellino3. We used confocal microscopy to complement these observations on the subcellular localization of IRF7. In unstimulated MEFs from wild-type mice, IRF7 localized to the cytoplasm, and stimulation with poly(I:C) promoted some nuclear accumulation of IRF7 (Fig. 4g) . However, the effect of poly(I:C) in Pellino3-deficient MEFs was more notable, with all detectable IRF7 translocating to the nucleus after poly(I:C) stimulation. Finally, we assessed whether the enhanced poly(I:C)-induced nuclear localization of IRF7 in Pellino3-deficient cells translated into increased binding of IRF7 to responsive promoters. We stimulated wildtype and Pellino3-deficient BMDMs with poly(I:C) and assayed the in vivo binding of IRF7 to the Ifnb1 promoter by chromatin immunoprecipitation. Poly(I:C)-induced binding of IRF7 to the Ifnb promoter was increased in Pellino3-deficient cells compared to that in wild-type BMDMs (Fig. 4h) .
All of the above data strongly indicate that Pellino3 negatively regulates activation of IRF7 but not of IRF3. We directly addressed this by assessing the effects of overexpressed Pellino3 on the induction of a cotransfected IRF3-regulated or IRF7-regulated reporter gene. Using this system, both spliced forms of Pellino3 inhibited poly(I:C)-induced activation of IRF7 but not of IRF3 ( Supplementary  Fig. 5a,b) , consistent with Pellino3 targeting the IRF7 pathway. We also characterized the regulatory effects of the spliced forms of Pellino3 on naturally occurring IRF7-responsive promoters. Both spliced forms inhibited poly(I:C)-induced activation of the Fig. 5c,d) . Furthermore, given that IRF7 binds to the PRDI/III domains of the IFNB promoter, we confirmed that Pellino3 targets this region of the IFNB promoter (Supplementary Fig. 5e ). These data suggest that Pellino3 regulates the nuclear translocation and activation of IRF7.
Pellino3 regulates TRAF6-dependent ubiquitination of IRF7
We next probed the mechanism by which Pellino3 can target the IRF7 pathway. Because loss of Pellino3 did not affect poly(I:C)-induced phosphorylation of TBK1, a known activator of IRF7, we investigated the effects of Pellino3 deficiency on the ubiquitination status of IRF7. Previous studies have demonstrated that ubiquitination of IRF7 is a prerequisite for IKKi-mediated phosphorylation and activation of IRF7 (refs. 40,41) . Poly(I:C) promoted a modest increase in the ubiquitination of IRF7 in MEFs from wild-type mice. This was considerably enhanced in MEFs from Peli3 −/− mice (Fig. 5a) . Given that TRAF6 has been shown to interact with and ubiquitinate IRF7 (refs. 40,41), we next probed the effects of Pellino3 on the TRAF6-IRF7 interaction. Poly(I:C) promoted the interaction of TRAF6 with IRF7 in wild-type MEFs, and this was augmented in Peli3 −/− MEFs, as shown by increased coimmunoprecipitation of TRAF6 and IRF7 (Fig. 5b) . Poly(I:C) did not induce IFN-β in MEFs from TRAF6-deficient mice (Fig. 5c) , demonstrating a functional role for TRAF6 in poly(I:C)-induced expression of type I interferon. This deficiency in TLR3 signaling was rescued by reconstitution of Traf6 −/− MEFs with wild-type TRAF6 but not with a point mutant form of TRAF6 (C70A) that obliterates its E3 ubiquitin ligase activity (Fig. 5d) . These results are consistent with a model in which Pellino3 targets TRAF6-induced ubiquitination of IRF7 and IFN-β expression downstream of TLR3.
Pellino3 mediates ubiquitination of TRAF6
We next investigated the regulatory process by which TLR3 deploys Pellino3 to negatively regulate TRAF6-mediated activation of IRF7. Poly(I:C) induced expression of Peli3 mRNA in wild-type BMDMs (Fig. 6a) but not in BMDMs lacking TRIF, TBK1 or IKKi. In addition, poly(I:C) promoted the interaction of Pellino3 with TRAF6 in a time-dependent manner, as evidenced by coimmunoprecipitation of the two proteins (Fig. 6b) . We probed the functional consequence of this interaction by measuring the ubiquitination of TRAF6 in wild-type and Pellino3-deficient cells. Because Pellino3 is an E3 ubiquitin ligase, we especially investigated the ubiquitination of TRAF6. Stimulation with poly(I:C) caused ubiquitination of TRAF6 in wild-type MEFs but not in MEFs from Peli3 −/− mice (Fig. 6c) , indicating an important role for Pellino3 in the ubiquitination of TRAF6 downstream of TLR3. This was also the case in human cells, as HEK293 cells stably expressing TLR3 and transfected with PELI3-specific shRNA did not exhibit increased ubiquitination of TRAF6 in response to poly(I:C), whereas cells transfected with control shRNAs strongly responded to poly(I:C) (Supplementary Fig. 6a ). 
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The responsiveness of Peli3 −/− MEFs to poly(I:C)-induced ubiquitination of TRAF6 was restored by retrovirally mediated expression of mouse Pellino3 (Supplementary Fig. 6b ). The E3 ligase activity of Pellino3 was directly required for the ubiquitination of TRAF6 because a mutant form of Pellino3 that lacks a functional RING domain did not reconstitute the poly(I:C)-induced ubiquitination of TRAF6 in Peli3 −/− MEFs (Fig. 6d) .
We next evaluated the functional link between the ability of Pellino3 to mediate poly(I:C)-induced ubiquitination of TRAF6 and the regulatory effects of Pellino3 on IFN-β expression. Reintroduction of mouse Pellino3 into Peli3 −/− MEFs blunted the ability of poly(I:C) to induce Ifnb1 mRNA and IFN-β protein, whereas the mutated form of Pellino3 with a nonfunctional RING domain did not exert this inhibitory influence (Fig. 6e) . This also applies to human cells because exogenous expression of Pellino3 in HEK293 TLR3 cells expressing PELI3-specific shRNA inhibited poly(I:C)-induced expression of IFN-β, whereas the RING-mutated form of Pellino3 was ineffective (Supplementary Fig. 6c ). We next explored whether ubiquitination of TRAF6 affects its capacity to ubiquitinate IRF7. As expected, the coexpression of TRAF6 and IRF7 led to strong ubiquitination of IRF7, and this was lost with a point mutation (C70A) of TRAF6 that interferes with the E3 ligase activity of TRAF6 (Fig. 6f) . However, mutation of the primary ubiquitination site in TRAF6 (Lys124) led to slightly higher levels of ubiquitinated IRF7, consistent with the idea that ubiquitination of TRAF6 has an inhibitory effect on its E3 ubiquitin ligase activity. Furthermore, the TRAF6 mutant lacking the ubiquitination site was more effective than its wild-type counterpart in reconstituting poly(I:C)-induced expression of IFN-β in TRAF6-knockdown cells (Fig. 6g) . These data are consistent with a model where poly(I:C) induces Pellino3 expression and promotes its interaction with and 
DISCUSSION
Using Pellino3-deficient mice, in this study we characterized the physiological role of Pellino3 in innate immunity. Peli3 −/− mice were viable and developed normally. Our data indicate that Pellino3 does not act as a mediator of proinflammatory cytokine expression in response to TLRs but has a key regulatory role in controlling TRIFdependent type I interferon expression in the TLR3 pathway. We propose that TLR3 specifically uses Pellino3 as part of an autoregulatory signaling network in which stimulation of TLR3 by viruses or defined ligands, such as dsRNA, leads to upregulation of Pellino3, facilitating its interaction with TRAF6 and ubiquitination of the latter. We propose that this modification of TRAF6 serves to terminate its ability to ubiquitinate IRF7, thus shutting down a key driver of type I interferon expression. In addition to delineating a new regulatory network that controls type I interferon expression, the findings also highlight a new function for Pellino proteins. Whereas overexpression and knockdown approaches have previously implicated Pellino proteins as regulators of the NF-κB and MAP kinase pathways, studies in a physiological setting have been restricted to Pellino1 (refs. 35, 36) . Using Pellino1-deficient mice, Pellino1 has been shown to regulate the NF-κB pathway and act as a key mediator of TRIF-induced expression of proinflammatory cytokines in the TLR3 and TLR4 pathways. Our present studies show that Pellino3 regulates TRIF-dependent signaling in a manner that is very different from that of Pellino1, in that Pellino3 regulates TRIF-induced expression of IFN-β. This emphasizes divergent functions for different members of the Pellino family and highlights specific roles for Pellino proteins in these pathways.
We used EMCV as a naturally occurring agent that triggers antiviral immunity via TLR3. TLR3 signaling is essential for mediating cytokine expression, viral clearance and reducing lethality in response to EMCV infection 39 . Our findings indicate that absence of Pellino3 leads to enhanced viral clearance, diminished pathology and greater survival in mice, and this is consistent with greatly augmented TLR3-induced expression of type I interferons in response to EMCV infection when Pellino3 is absent. This reaffirms a critical role for Pellino3 in tempering type I interferon expression in response to TLR3 stimulation. However, our findings cannot exclude a role for Pellino3 in similarly regulating the signaling of the viral sensing retinoic acidinducible gene (RIG-I)-like receptors, as Mda-5 has also been reported to detect poly(I:C) and act as a sensor of EMCV infection and as a mediator of EMCV-driven type I interferon expression 38 . However, responses to poly(I:C) mediated by Mda-5 require cell transfection to facilitate delivery of the synthetic dsRNA to the cytosol-resident Mda-5. Under conditions of transfection-mediated delivery, we showed that loss of Pellino3 was without effect, strongly suggesting that Pellino3 targets the TLR3 pathway and not the Mda-5 pathway. Furthermore, using our delivery protocol, we observed loss of cytokine induction in response to poly(I:C) in TRIF-deficient BMDMs but not in MAVS-deficient BMDMs, reaffirming that Pellino3 is targeting the TLR3 pathway.
In our model, Pellino3 negatively regulates ubiquitination, nuclear translocation and activation of IRF7, and thus inhibits a major driver behind type I interferon expression. In searching for the mechanism by which Pellino3 could exert such effects on IRF7 activation we looked beyond its immediate upstream kinases, TBK1 and IKKi, given that loss of Pellino3 did not affect poly(I:C)-induced phosphorylation of TBK1. A previous study has shown that Epstein-Barr virus LMP1 uses TRAF6 to ubiquitinate IRF7 on its last three lysine residues, with such ubiquitination being a prerequisite for IKKi-mediated phosphorylation and activation of IRF7 (ref. 41 ). TRAF6 also has been shown to fulfill a critically important role in the ubiquitination and activation of IRF7 by TLR7 and TLR9 in pDCs 40 . TRAF6 has a role in the activation of the IFN-β promoter by poly(I:C) and EMCV, with the replication of EMCV being considerably enhanced in the absence of TRAF6 (ref. 42 ). These reports closely mirrored our findings in Pellino3-deficient mice and promote TRAF6 as the lead target for Pellino3.
We found that TLR3 signaling promoted the interaction of Pellino3 with TRAF6, leading to strong ubiquitination of TRAF6, which depended on the functional RING-like domain in Pellino3. These observations strongly suggest that Pellino3 acts as the immediate E3 ubiquitin ligase for TRAF6. However, this does not exclude the possibility that Pellino3 associates with TRAF6 and stimulates the autoubiquitination of TRAF6. In an in vitro ubiquitination assay, we did not observe direct ubiquitination of TRAF6 by recombinant Pellino3. This may be due to recombinant Pellino3 lacking some prerequisite modification or ancillary protein to manifest its E3 ligase activity to TRAF6. Indeed the E3 ligase catalytic activity of Pellino proteins is strongly enhanced by phosphorylation [24] [25] [26] [27] [28] , and in the context of TLR3 signaling it is especially interesting to note that Pellino1 is induced and activated by TBK1 and IKKi 26 . We showed here that the expression of Pellino3 similarly depends on TBK1-IKKi. Thus it is plausible to extrapolate a model where TLR3 signaling uses TBK1 and IKKi, in an analogous manner to Pellino1, to phosphorylate and activate Pellino3, thus leading to ubiquitination of TRAF6.
We also propose that Pellino3-mediated ubiquitination of TRAF6 negatively influences the ability of TRAF6 to ubiquitinate IRF7. Although the ubiquitination of TRAF6 has been originally proposed to serve to bring TAK1 and IKK complexes into close proximity, thus allowing for IKK activation and downstream activation of NF-κB 43 , this model has been questioned recently. Thus, a mutant form of TRAF6 that is refractory to ubiquitination can still trigger activation of NF-κB 44 , and TRAF6 can generate unanchored polyubiquitin chains to trigger downstream activation of NF-κB 45 . We now propose a new role for ubiquitination of TRAF6 in that it suppresses the ubiquitination of IRF7 by decreasing the interaction of TRAF6 with IRF7. It is intriguing that Pellino3 should counterregulate interferon expression by targeting the TRAF6-IRF7 interaction, as the Thogoto virus uses its ML protein as a virulence factor to inhibit the expression of type I interferons by also blocking the interaction of TRAF6 with IRF7 (ref. 46 ). This highlights a critical involvement for TRAF6-mediated ubiquitination of IRF7 in the induction of type I interferons. Given such an important role, it is not surprising that a physiological regulatory system modulates this part of the pathway to control type I interferon expression, whereas viruses target this pathway to subvert antiviral innate immunity.
Pellino proteins are very highly conserved throughout evolution, and so the notion of a Pellino gene being evolutionarily retained to counter a key antiviral strategy of producing type I interferon appears counterintuitive. However, the expression of type I interferons must be tightly controlled because excessive production can contribute to autoimmune inflammatory diseases 47 . It will be interesting to explore whether naturally occurring defective forms or expression of Pellino3 may provide a genetic basis to some cases of interferon-driven inflammatory disease. Such studies in conjunction with the present findings will help understand the physiological and pathological roles of the Pellino family.
METHODS
Methods and any associated references are available in the online version of the paper. 
